Risk assessment of tetrabromobisphenol a on cyclooxygenase-2 expression via map kinase/NF-B/AP-1 signaling pathways in murine macrophages

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 21-22, 2009, Pages 1431-1438

  Han, Eun Hee ^a   Park, Jin Hee ^a   Kang, Keon Wook ^a   Jeong, Tae Cheon ^b   Kim, Hyung Sik ^c   Jeong, Hye Gwang ^a,d  

^a Chosun University   (South Korea)

^b Yeungnam University   (South Korea)

^c Pusan National University   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; TETRABROMOBISPHENOL A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; FLAME RETARDANT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; POLYBROMINATED BIPHENYL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; GENETIC TRANSFECTION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM;

MURINAE;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FLAME RETARDANTS; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOLECULAR STRUCTURE; NF-KAPPA B; POLYBROMINATED BIPHENYLS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 75749143941     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903212873     Document Type: Article

References (34)

1. DeWitt, D. L. 1991. Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim. Biophys. Acta 1083:121-134.
2. Fletcher, J. R. 1993. Eicosanoids. Critical agents in the physiological process and cellular injury. Arch. Surg. 128:1192-1196.
3. Fonnum, F., Mariussen, E., and Reistad, T. 2006. Molecular mechanisms involved in the toxic effects of polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs). J. Toxicol. Environ. Health A 69:21-35.
4. Guan, Z., Buckman, S. Y., Miller, B. W., Springer, L. D., and Morrison, A. R. 1998. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem. 273:28670-28676.
5. Guo, Y. S., Hellmich, M. R., Wen, X. D., and Townsend, C. M., Jr. 2001. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J. Biol. Chem. 276:22941-22947.
6. Helleday, T., Tuominen, K. L., Bergman, A., and Jenssen, D. 1999. Brominated flame retardants induce intragenic recombination in mammalian cells. Mutat. Res. 439:137-147.
7. Herschman, H. R. 1996. Prostaglandin synthase 2. Biochim. Biophys. Acta 1299(1):125-140.
8. Inoue, H., Nanayama, T., Hara, S., Yokoyama, C., and Tanabe, T. 1994. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett. 350:51-54.
9. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T. 1995. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 270:24965-24971.
10. Kitamura, S., Jinno, N., Ohta, S., Kuroki, H., and Fujimoto, N. 2002. Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A. Biochem. Biophys. Res. Commun. 293:554-559.
11. Kosaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E., and Tanabe, T. 1994. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. 221:889-897. (Pubitemid 24146188)
12. Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., and Dannenberg, A. J. 1997. Retinoids suppress phorbol estermediated induction of cyclooxygenase-2. Cancer Res. 57:1081-1085.
13. Nakagawa, Y., Suzuki, T., Ishii, H., and Ogata, A. 2007. Biotransformation and cytotoxicity of a brominated flame retardant, tetrabromobisphenol A, and its analogues in rat hepatocytes. Xenobiotica 37:693-708.
14. Nanayama, T., Hara, S., Inoue, H., Yokoyama, C., and Tanabe, T. 1995. Regulation of two isozymes of prostaglandin endoperoxide synthase and thromboxane synthase in human monoblastoid cell line U937. Prostaglandins 49:371-382.
15. Paul, A., Cuenda, A., Bryant, C. E., Murray, J., Chilvers, E. R., Cohen, P., Gould, G. W., and Plevin, R. 1999. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclooxygenase-2 but not nitric oxide synthase in RAW264.7 macrophages. Cell Signal 11:491-497.
16. Pommery, N., and Henichart, J. P. 2005. Involvement of PI3K/Akt pathway in prostate cancer--potential strategies for developing targeted therapies. Mini Rev. Med. Chem. 5:1125-1132. (Pubitemid 41723569)
17. Prescott, S. M., and Fitzpatrick, F. A. 2000. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470:M69-M78.
18. Pullen, S., Boecker, R., and Tiegs, G. 2003. The flame retardants tetrabromobisphenol A and tetrabromobisphenol A-bisallylether suppress the induction of interleukin-2 receptor alpha chain (CD25) in murine splenocytes. Toxicology 184:11-22.
19. Reistad, T., Mariussen, E., Ring, A., and Fonnum, F. 2007. In vitro toxicity of tetrabromobisphenol-A on cerebellar granule cells: Cell death, free radical formation, calcium influx and extracellular glutamate. Toxicol. Sci. 96:268-278.
20. Ridley, S. H., Dean, J. L., Sarsfield, S. J., Brook, M., Clark, A. R., and Saklatvala, J. 1998. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:75-80.
21. Riese, J., Hoff, T., Nordhoff, A., DeWitt, D. L., Resch, K., and Kaever, V. 1994. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J. Leukocyte Biol. 55:476-482. (Pubitemid 24122524)
22. Roth, G. J., and Calverley, D. C. 1994. Aspirin, platelets, and thrombosis: theory and practice. Blood 83:885-898.
23. Scherle, P. A., Jones, E. A., Favata, M. F., Daulerio, A. J., Covington, M. B., Nurnberg, S. A., Magolda, R. L., and Trzaskos, J. M. 1998. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 161:5681-5686.
24. Simon, L. S. 1999. Role and regulation of cyclooxygenase-2 during inflammation. Am. J. Med. 106:37S-2S.
25. Smith, W. L., and Marnett, L. J. 1991. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim. Biophys. Acta 1083:1-17.
26. Strack, S., Detzel, T., Wahl, M., Kuch, B., and Krug, H. F. 2007. Cytotoxicity of TBBPA and effects on proliferation, cell cycle and MAPK pathways in mammalian cells. Chemosphere 67:S405-S411.
27. Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., and Dannenberg, A. J. 1996. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424-4429.
28. Wadleigh, D. J., Reddy, S. T., Kopp, E., Ghosh, S., and Herschman, H. R. 2000. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275:6259-6266.
29. Whitmarsh, A. J., and Davis, R. J. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74(10):589-607.
30. Williams, J. A., and Shacter, E. 1997. Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem. 272:25693-25699.
31. Williams, T. J., and Morley, J. 1973. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 24:215-217.
32. Xie, W., Fletcher, B. S., Andersen, R. D., and Herschman, H. R. 1994. v-src Induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol. Cell. Biol. 14:653-6539.
33. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. 1995. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270:31315-31320.
34. Zhou, H. R., Islam, Z., and Pestka, J. J. 2003. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. Toxicol. Sci. 72:130-142.